Global Kidney Transplantation Therapeutics Market 2019-2023 | Rising Prevalence of CKD and Renal Impairments to Boost Demand | Technavio

LONDON–(BUSINESS WIRE)–#Biotechnology–The global kidney transplantation therapeutics market size is poised to grow by USD 1.02 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 4% during the forecast period.

Read the 129-page research report with TOC on “Kidney Transplantation Therapeutics Market Analysis Report by product (selective cytokine inhibitors, immunosuppressive antimetabolites, and other drugs), and geography (North America, Europe, Asia, and ROW) 2019 – 2023”. Request a Free Sample Report

The market is driven by the high dependency on immunosuppressants for kidney transplantation. In addition, the rising prevalence of CKD and renal impairments to further boost the growth of the kidney transplantation therapeutics market.

The market has witnessed significant advances in surgical and ancillary healthcare techniques in recent years. Such advances are driving the demand for kidney transplantation. However, graft rejection is a major challenge associated with kidney transplantation. To overcome this challenge, vendors have developed immunosuppressants. Patients are required to undergo maintenance therapy using immunosuppressants for the rest of their lives to reduce the risk of the transplanted organ getting rejected by the body. Thus, the increasing cases of kidney transplantation and risks associated with transplant rejection are driving the kidney transplantation therapeutics market.

The burden of CKD is increasing worldwide, owing to the increasing cases of non-communicable diseases and their risk factors. In most of the underdeveloped and developing countries, glomerulonephritis and interstitial nephritis are the two major causes of CKD, owing to the high prevalence of infections. Thus, the rising prevalence of CKD is expected to increase the need for kidney transplantation, thereby, boosting demand for kidney transplantation therapeutics during the forecast period.

For More Information: Request Free Sample Pages

The report includes detailed profiles of the leading companies & prominent vendors of the market:

• Astellas Pharma Inc.
• F. Hoffmann-La Roche Ltd.
• Mylan NV
• Novartis AG
• Veloxis Pharmaceuticals A/S

Market Segmentation by Product:

The kidney transplantation therapeutics market can be broadly categorized into the following segments:

• Selective cytokine inhibitors
• Immunosuppressive antimetabolites
• Other drugs

Key Regions for the Kidney Transplantation Therapeutics Market:

Featuring a breakdown of region-wise market shares until 2019.

• North America
• Europe
• Asia
• ROW

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare are:

Kidney Stones Management Devices Market – Global Kidney Stones Management Devices Market by procedure (URS, ESWL, and PCNL) and geography (Asia, Europe, North America, and ROW).

Polycystic Kidney Disease Drugs Market – Global Polycystic Kidney Disease Drugs Market by type (ADPKD and ARPKD) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com